Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals Cyclin E as the best candidate gene for this amplicon

Genomic DNA amplification in tumors is frequently associated with an increased gene copy number of oncogenes or other cancer-related genes. We have used a two-dimensional whole-genome scanning technique to identify gene amplification events in esophageal adenocarcinomas. A multicopy genomic fragment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2000-12, Vol.60 (24), p.7021-7027
Hauptverfasser: LIN LIN, PRESCOTT, Michael S, ZHOUQIN ZHU, PUJA SINGH, CHUN, Sang Y, KUICK, Rork D, HANASH, Samir M, ORRINGER, Mark B, GLOVER, Thomas W, BEER, David G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7027
container_issue 24
container_start_page 7021
container_title Cancer research (Chicago, Ill.)
container_volume 60
creator LIN LIN
PRESCOTT, Michael S
ZHOUQIN ZHU
PUJA SINGH
CHUN, Sang Y
KUICK, Rork D
HANASH, Samir M
ORRINGER, Mark B
GLOVER, Thomas W
BEER, David G
description Genomic DNA amplification in tumors is frequently associated with an increased gene copy number of oncogenes or other cancer-related genes. We have used a two-dimensional whole-genome scanning technique to identify gene amplification events in esophageal adenocarcinomas. A multicopy genomic fragment from a tumor two-dimensional gel was cloned, and genomic amplification encompassing this fragment was confirmed by Southern blot analysis. The corresponding DNA sequence was matched by BLAST to a BAC contig, which allowed the use of electronic-PCR to localize this amplicon to 19q12. Sequence tagged site-amplification mapping, an approach recently implemented in our laboratory (Lin, L. et al., Cancer Res., 60: 1341-1347,2000), was used to characterize the amplicon. Genomic DNA from 65 esophageal and 11 gastric cardia adenocarcinomas were investigated for 19q12 amplification using quantitative PCR at 11 sequence tagged site markers neighboring the cloned fragment. The amplicon was narrowed from >8 cM to a minimal critical region spanning
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72537275</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72537275</sourcerecordid><originalsourceid>FETCH-LOGICAL-h300t-8c082d682b9e00e9ef0c2257f2c26189cdfe3d6d2a3d6f455e8efe1e3cfdabf53</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhoMotlb_giwI3gL7kc3HUUrVQsGLnsNkd7ZZSTbpbirUv-EfdqG1Vy8zzDvPvDPMRTJnUpRpkWXyMplTSstUZgWfJTchfMZSMiqvkxljTOYZzefJz1qjm6yxCiY7OAJOE9WCBzWht99HcTAECKt2jBPox86qqFlHMAxjC1uEjkB0GRR4Zd3QQyAev6IcyPKgukiuSNSmFkmDYSIqLrEaJiRbdEjM4GPPhrP3bXJl4jDenfIi-XhevS9f083by3r5tElbQemUloqWXOclbyqkFCs0VHEuC8MVz1lZKW1Q6FxziNFkUmKJBhkKZTQ0RopF8nj0Hf2w28fL6t4GhV0HDod9qAsuRcGL_0FWVExIxiJ4fwL3TY-6Hr3twR_qv39H4OEEQFDQGQ9O2XDmyqwqKBe_vOiMGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17913511</pqid></control><display><type>article</type><title>Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals Cyclin E as the best candidate gene for this amplicon</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>LIN LIN ; PRESCOTT, Michael S ; ZHOUQIN ZHU ; PUJA SINGH ; CHUN, Sang Y ; KUICK, Rork D ; HANASH, Samir M ; ORRINGER, Mark B ; GLOVER, Thomas W ; BEER, David G</creator><creatorcontrib>LIN LIN ; PRESCOTT, Michael S ; ZHOUQIN ZHU ; PUJA SINGH ; CHUN, Sang Y ; KUICK, Rork D ; HANASH, Samir M ; ORRINGER, Mark B ; GLOVER, Thomas W ; BEER, David G</creatorcontrib><description>Genomic DNA amplification in tumors is frequently associated with an increased gene copy number of oncogenes or other cancer-related genes. We have used a two-dimensional whole-genome scanning technique to identify gene amplification events in esophageal adenocarcinomas. A multicopy genomic fragment from a tumor two-dimensional gel was cloned, and genomic amplification encompassing this fragment was confirmed by Southern blot analysis. The corresponding DNA sequence was matched by BLAST to a BAC contig, which allowed the use of electronic-PCR to localize this amplicon to 19q12. Sequence tagged site-amplification mapping, an approach recently implemented in our laboratory (Lin, L. et al., Cancer Res., 60: 1341-1347,2000), was used to characterize the amplicon. Genomic DNA from 65 esophageal and 11 gastric cardia adenocarcinomas were investigated for 19q12 amplification using quantitative PCR at 11 sequence tagged site markers neighboring the cloned fragment. The amplicon was narrowed from &gt;8 cM to a minimal critical region spanning &lt;0.8 cM, between D19S919 and D19S882. This region includes the cyclin E gene. Fourteen expressed sequence tags (ESTs) covering the minimal region were then assayed for potential gene overexpression using quantitative reverse transcription-PCR. Seven of the selected ESTs were found to be both amplified and overexpressed. Among these seven ESTs, cyclin E showed the highest frequency of gene amplification and overexpression in the tumors examined, which allowed us to finalize the core-amplified region to &lt;300 kb. These results indicate that cyclin E is the likely target gene selected by the amplification event at 19q12. The fact that cyclin E overexpression was found only in the amplified tumors examined indicates that gene amplification underlies the cyclin E gene overexpression. Our study represents the first extensive analysis of the 19q12 amplicon, and is the first to physically map the core-amplified domain to a region of &lt;300 kb that includes cyclin E. Amplification of 19q12 was found neither in the 28 esophageal squamous cancers nor in the 39 lung adenocarcinomas examined but was observed in 13.8% of esophageal and 9.1% of gastric cardia adenocarcinomas.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 11156406</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adenocarcinoma - genetics ; Biological and medical sciences ; Blotting, Southern ; Carcinoma, Squamous Cell - genetics ; Carcinoma, Squamous Cell - pathology ; chromosome 19 ; Chromosome Mapping ; Chromosomes, Human, Pair 19 ; Cloning, Molecular ; Contig Mapping ; Cyclin E - biosynthesis ; Cyclin E - genetics ; Electrophoresis, Gel, Two-Dimensional ; Esophageal Neoplasms - genetics ; Esophageal Neoplasms - metabolism ; Esophageal Neoplasms - pathology ; Esophagus ; Esophagus - metabolism ; Esophagus - pathology ; Expressed Sequence Tags ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Lung Neoplasms - genetics ; Medical sciences ; Models, Genetic ; Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; Stomach Neoplasms - genetics ; Stomach Neoplasms - pathology ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2000-12, Vol.60 (24), p.7021-7027</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=849702$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11156406$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LIN LIN</creatorcontrib><creatorcontrib>PRESCOTT, Michael S</creatorcontrib><creatorcontrib>ZHOUQIN ZHU</creatorcontrib><creatorcontrib>PUJA SINGH</creatorcontrib><creatorcontrib>CHUN, Sang Y</creatorcontrib><creatorcontrib>KUICK, Rork D</creatorcontrib><creatorcontrib>HANASH, Samir M</creatorcontrib><creatorcontrib>ORRINGER, Mark B</creatorcontrib><creatorcontrib>GLOVER, Thomas W</creatorcontrib><creatorcontrib>BEER, David G</creatorcontrib><title>Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals Cyclin E as the best candidate gene for this amplicon</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Genomic DNA amplification in tumors is frequently associated with an increased gene copy number of oncogenes or other cancer-related genes. We have used a two-dimensional whole-genome scanning technique to identify gene amplification events in esophageal adenocarcinomas. A multicopy genomic fragment from a tumor two-dimensional gel was cloned, and genomic amplification encompassing this fragment was confirmed by Southern blot analysis. The corresponding DNA sequence was matched by BLAST to a BAC contig, which allowed the use of electronic-PCR to localize this amplicon to 19q12. Sequence tagged site-amplification mapping, an approach recently implemented in our laboratory (Lin, L. et al., Cancer Res., 60: 1341-1347,2000), was used to characterize the amplicon. Genomic DNA from 65 esophageal and 11 gastric cardia adenocarcinomas were investigated for 19q12 amplification using quantitative PCR at 11 sequence tagged site markers neighboring the cloned fragment. The amplicon was narrowed from &gt;8 cM to a minimal critical region spanning &lt;0.8 cM, between D19S919 and D19S882. This region includes the cyclin E gene. Fourteen expressed sequence tags (ESTs) covering the minimal region were then assayed for potential gene overexpression using quantitative reverse transcription-PCR. Seven of the selected ESTs were found to be both amplified and overexpressed. Among these seven ESTs, cyclin E showed the highest frequency of gene amplification and overexpression in the tumors examined, which allowed us to finalize the core-amplified region to &lt;300 kb. These results indicate that cyclin E is the likely target gene selected by the amplification event at 19q12. The fact that cyclin E overexpression was found only in the amplified tumors examined indicates that gene amplification underlies the cyclin E gene overexpression. Our study represents the first extensive analysis of the 19q12 amplicon, and is the first to physically map the core-amplified domain to a region of &lt;300 kb that includes cyclin E. Amplification of 19q12 was found neither in the 28 esophageal squamous cancers nor in the 39 lung adenocarcinomas examined but was observed in 13.8% of esophageal and 9.1% of gastric cardia adenocarcinomas.</description><subject>Adenocarcinoma - genetics</subject><subject>Biological and medical sciences</subject><subject>Blotting, Southern</subject><subject>Carcinoma, Squamous Cell - genetics</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>chromosome 19</subject><subject>Chromosome Mapping</subject><subject>Chromosomes, Human, Pair 19</subject><subject>Cloning, Molecular</subject><subject>Contig Mapping</subject><subject>Cyclin E - biosynthesis</subject><subject>Cyclin E - genetics</subject><subject>Electrophoresis, Gel, Two-Dimensional</subject><subject>Esophageal Neoplasms - genetics</subject><subject>Esophageal Neoplasms - metabolism</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophagus</subject><subject>Esophagus - metabolism</subject><subject>Esophagus - pathology</subject><subject>Expressed Sequence Tags</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Lung Neoplasms - genetics</subject><subject>Medical sciences</subject><subject>Models, Genetic</subject><subject>Polymerase Chain Reaction</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach Neoplasms - pathology</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1Lw0AQhoMotlb_giwI3gL7kc3HUUrVQsGLnsNkd7ZZSTbpbirUv-EfdqG1Vy8zzDvPvDPMRTJnUpRpkWXyMplTSstUZgWfJTchfMZSMiqvkxljTOYZzefJz1qjm6yxCiY7OAJOE9WCBzWht99HcTAECKt2jBPox86qqFlHMAxjC1uEjkB0GRR4Zd3QQyAev6IcyPKgukiuSNSmFkmDYSIqLrEaJiRbdEjM4GPPhrP3bXJl4jDenfIi-XhevS9f083by3r5tElbQemUloqWXOclbyqkFCs0VHEuC8MVz1lZKW1Q6FxziNFkUmKJBhkKZTQ0RopF8nj0Hf2w28fL6t4GhV0HDod9qAsuRcGL_0FWVExIxiJ4fwL3TY-6Hr3twR_qv39H4OEEQFDQGQ9O2XDmyqwqKBe_vOiMGQ</recordid><startdate>20001215</startdate><enddate>20001215</enddate><creator>LIN LIN</creator><creator>PRESCOTT, Michael S</creator><creator>ZHOUQIN ZHU</creator><creator>PUJA SINGH</creator><creator>CHUN, Sang Y</creator><creator>KUICK, Rork D</creator><creator>HANASH, Samir M</creator><creator>ORRINGER, Mark B</creator><creator>GLOVER, Thomas W</creator><creator>BEER, David G</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20001215</creationdate><title>Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals Cyclin E as the best candidate gene for this amplicon</title><author>LIN LIN ; PRESCOTT, Michael S ; ZHOUQIN ZHU ; PUJA SINGH ; CHUN, Sang Y ; KUICK, Rork D ; HANASH, Samir M ; ORRINGER, Mark B ; GLOVER, Thomas W ; BEER, David G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h300t-8c082d682b9e00e9ef0c2257f2c26189cdfe3d6d2a3d6f455e8efe1e3cfdabf53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Biological and medical sciences</topic><topic>Blotting, Southern</topic><topic>Carcinoma, Squamous Cell - genetics</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>chromosome 19</topic><topic>Chromosome Mapping</topic><topic>Chromosomes, Human, Pair 19</topic><topic>Cloning, Molecular</topic><topic>Contig Mapping</topic><topic>Cyclin E - biosynthesis</topic><topic>Cyclin E - genetics</topic><topic>Electrophoresis, Gel, Two-Dimensional</topic><topic>Esophageal Neoplasms - genetics</topic><topic>Esophageal Neoplasms - metabolism</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophagus</topic><topic>Esophagus - metabolism</topic><topic>Esophagus - pathology</topic><topic>Expressed Sequence Tags</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Lung Neoplasms - genetics</topic><topic>Medical sciences</topic><topic>Models, Genetic</topic><topic>Polymerase Chain Reaction</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach Neoplasms - pathology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LIN LIN</creatorcontrib><creatorcontrib>PRESCOTT, Michael S</creatorcontrib><creatorcontrib>ZHOUQIN ZHU</creatorcontrib><creatorcontrib>PUJA SINGH</creatorcontrib><creatorcontrib>CHUN, Sang Y</creatorcontrib><creatorcontrib>KUICK, Rork D</creatorcontrib><creatorcontrib>HANASH, Samir M</creatorcontrib><creatorcontrib>ORRINGER, Mark B</creatorcontrib><creatorcontrib>GLOVER, Thomas W</creatorcontrib><creatorcontrib>BEER, David G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LIN LIN</au><au>PRESCOTT, Michael S</au><au>ZHOUQIN ZHU</au><au>PUJA SINGH</au><au>CHUN, Sang Y</au><au>KUICK, Rork D</au><au>HANASH, Samir M</au><au>ORRINGER, Mark B</au><au>GLOVER, Thomas W</au><au>BEER, David G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals Cyclin E as the best candidate gene for this amplicon</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2000-12-15</date><risdate>2000</risdate><volume>60</volume><issue>24</issue><spage>7021</spage><epage>7027</epage><pages>7021-7027</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Genomic DNA amplification in tumors is frequently associated with an increased gene copy number of oncogenes or other cancer-related genes. We have used a two-dimensional whole-genome scanning technique to identify gene amplification events in esophageal adenocarcinomas. A multicopy genomic fragment from a tumor two-dimensional gel was cloned, and genomic amplification encompassing this fragment was confirmed by Southern blot analysis. The corresponding DNA sequence was matched by BLAST to a BAC contig, which allowed the use of electronic-PCR to localize this amplicon to 19q12. Sequence tagged site-amplification mapping, an approach recently implemented in our laboratory (Lin, L. et al., Cancer Res., 60: 1341-1347,2000), was used to characterize the amplicon. Genomic DNA from 65 esophageal and 11 gastric cardia adenocarcinomas were investigated for 19q12 amplification using quantitative PCR at 11 sequence tagged site markers neighboring the cloned fragment. The amplicon was narrowed from &gt;8 cM to a minimal critical region spanning &lt;0.8 cM, between D19S919 and D19S882. This region includes the cyclin E gene. Fourteen expressed sequence tags (ESTs) covering the minimal region were then assayed for potential gene overexpression using quantitative reverse transcription-PCR. Seven of the selected ESTs were found to be both amplified and overexpressed. Among these seven ESTs, cyclin E showed the highest frequency of gene amplification and overexpression in the tumors examined, which allowed us to finalize the core-amplified region to &lt;300 kb. These results indicate that cyclin E is the likely target gene selected by the amplification event at 19q12. The fact that cyclin E overexpression was found only in the amplified tumors examined indicates that gene amplification underlies the cyclin E gene overexpression. Our study represents the first extensive analysis of the 19q12 amplicon, and is the first to physically map the core-amplified domain to a region of &lt;300 kb that includes cyclin E. Amplification of 19q12 was found neither in the 28 esophageal squamous cancers nor in the 39 lung adenocarcinomas examined but was observed in 13.8% of esophageal and 9.1% of gastric cardia adenocarcinomas.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>11156406</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2000-12, Vol.60 (24), p.7021-7027
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_72537275
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Adenocarcinoma - genetics
Biological and medical sciences
Blotting, Southern
Carcinoma, Squamous Cell - genetics
Carcinoma, Squamous Cell - pathology
chromosome 19
Chromosome Mapping
Chromosomes, Human, Pair 19
Cloning, Molecular
Contig Mapping
Cyclin E - biosynthesis
Cyclin E - genetics
Electrophoresis, Gel, Two-Dimensional
Esophageal Neoplasms - genetics
Esophageal Neoplasms - metabolism
Esophageal Neoplasms - pathology
Esophagus
Esophagus - metabolism
Esophagus - pathology
Expressed Sequence Tags
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Lung Neoplasms - genetics
Medical sciences
Models, Genetic
Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
Stomach Neoplasms - genetics
Stomach Neoplasms - pathology
Tumors
title Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals Cyclin E as the best candidate gene for this amplicon
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T14%3A41%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20and%20characterization%20of%20a%2019q12%20amplicon%20in%20esophageal%20adenocarcinomas%20reveals%20Cyclin%20E%20as%20the%20best%20candidate%20gene%20for%20this%20amplicon&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=LIN%20LIN&rft.date=2000-12-15&rft.volume=60&rft.issue=24&rft.spage=7021&rft.epage=7027&rft.pages=7021-7027&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72537275%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17913511&rft_id=info:pmid/11156406&rfr_iscdi=true